- About Us
- Career Center
- Nano-Social Network
- Nano Consulting
- My Account
Ten teams at Purdue University and Indiana University will receive $50,000 each for research ranging from efforts to improve detection of colon cancer to creating precise 3-D models of the molecular structure of viruses.
Three projects are part of the second round of the Collaborations in Life Sciences and Informatics Research competition, which is funded by Purdue and IU. Seven other teams were funded through the Collaborations in Biomedical Research program, which supports research between faculty at Purdue and the Indiana University School of Medicine.
"These 10 shared awards totaling $500,000 are designed to lead to increased capability for the collaborators to compete successfully for larger federal grants," said Charles O. Rutledge, vice president for research at Purdue. "This program also helps spark quality research between our two universities, and these projects are advancing interdisciplinary opportunities here and at IU."
Michael A. McRobbie, IU president-elect, said these initiatives go well beyond the research and the labs at Indiana's two leading public universities.
"Support for these innovative, new collaborative projects through these two programs continues to allow us to more effectively leverage the resources and strengths of both of the state's major research universities," McRobbie said. "These grants also are targeted for areas that are especially promising for economic development in the state."
The life sciences projects focus on advancements in proteomics, the characteristics of biofilms and their applications in wastewater processing, and the use of cryoelectronics for developing models to examine more precisely the characteristics of a virus. Researchers will utilize labs on both campuses, including the Birck Nanotechnology Center at Purdue's Discovery Park, to perform the three projects:
• Olga Vitek, Purdue assistant professor of statistics and computer science, is working with Predrag Radivojac, IU assistant professor of informatics, to develop a procedure for improving how protein building blocks, called peptides, are identified by using a mass spectrometer. Researchers also will try to control the number of falsely identified proteins.
• Purdue biology professor Stanton Gelvin is collaborating with William Fuqua, an associate professor of biology at IU, to genetically engineer agrobacterium biofilms, which are used to process wastewater. Biofilms pose problems for manufacturing, agricultural and medical industries because they coat and clog surfaces. But they are beneficial in certain applications, especially wastewater processing. Research will be done in the Department of Biological Sciences at Purdue's West Lafayette campus.
• Bogdan Dragnea, IU assistant professor of chemistry, is collaborating with Lia Stanciu, Purdue assistant professor of materials engineering, in testing the hypothesis that a technique called cryoelectronic microscopy can be used to create 3-D images to generate a realistic model of the molecular arrangement in a virus. In cryoelectron microscopy, samples are frozen before being viewed with an electronic microscope. The research will be performed at Purdue's School of Materials Engineering and Birck Nanotechnology Center and at IU's Department of Chemistry.
Funded projects through the latest round of the Collaborations in Biomedical Research program will study areas ranging from using metabolomics to help detect colon cancer to inserting a micro-wireless sensor into the body for medical treatment. Those seven projects are:
• Metabolomics-based detection of colon cancer — Daniel Raftery of Purdue and Elena Chiorean at IU.
• Biomechanics of fatigue failure in osteoporosis and understanding long-term effects of treatment options — Thomas Siegmund of Purdue and David Burr of IU.
• A proteomics approach to molecular connections between metabolic syndrome and coronary artery disease — Andy Tao of Purdue and Michael Sturek of IU.
• Role of a protein called Cdc42 in insulin secretion from pancreatic beta cells — Debbie Thurmond of IU and Greg Hockerman at Purdue.
• Using a mass-spectrometry technique called LC-MS to analyze blood samples from research in cardiovascular disease — Vitek at Purdue and Susanne Ragg at IU.
• Drugs that inhibit production of an enzyme called PTP1B as anti-diabetes and obesity agents — Zhong-Yin Zhang of IU and Richard Borch at Purdue.
• An implantable microdevice for wireless measurement of intraocular pressure in humans — Babak Ziaie of Purdue and Louis Cantor at IU.
About Indiana University
Research today cuts across the boundaries of academic disciplines and institutions. Indiana University is a leader in fostering the multidisciplinary research essential to solving challenges of life and health. It is also a leader in forming the partnerships with business, industry, government, and other academic institutions that lead to important research and development and economic growth.
For more information, please click here
Charles O. Rutledge
Purdue University vice president for research
For general information about Purdue, Phillip Fiorini
Michael A. McRobbie or for general information about Indiana University, please contact
Copyright © Indiana UniversityIf you have a comment, please Contact us.
Issuers of news releases, not 7th Wave, Inc. or Nanotechnology Now, are solely responsible for the accuracy of the content.
|Related News Press|
FEI Partners With the George Washington University to Equip New Science & Engineering Hall: Suite of new high-performance microscopes will be used for cutting-edge experiments at GW’s new research facility April 29th, 2015
What makes cancer cells spread? New device offers clues May 19th, 2015
International and U.S. Students and Teachers Headed to Toronto for 34th Annual International Space Development Conference®: Students competed in prestigious NSS-NASA Ames Space Settlement Design Contest May 9th, 2015
DiATOME enables surface preparation for AFM and FIB May 19th, 2015
Efficiency record for black silicon solar cells jumps to 22.1 percent: Aalto University's researchers improved their previous record by over 3 absolute percents in cooperation with Universitat Politècnica de Catalunya May 18th, 2015
Organic nanoparticles, more lethal to tumors: Carbon-based nanoparticles could be used to sensitize cancerous tumors to proton radiotherapy and induce more focused destruction of cancer cells, a new study shows May 18th, 2015